Complete Dose Comparison: Wegovy To Mounjaro Switch Options
Why Consider Switching From Wegovy To Mounjaro?
The decision between Wegovy to Mounjaro often comes down to mechanism and individual response. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your natural fullness hormone, whilst Mounjaro contains tirzepatide—a dual agonist targeting both GIP and GLP-1 receptors. Some patients find Mounjaro's dual pathway approach suits their metabolism better, particularly if Wegovy's appetite reduction effects plateau at higher doses. At EverydayMeds, we maintain complete stock of both treatments across all dose strengths, ensuring your prescriber can seamlessly transition you without supply interruptions.
Our clinical team (GPhC #9012878) manages thousands of Wegovy to Mounjaro transitions annually. The key advantage isn't just having both treatments available—it's maintaining every single dose from initial 0.25mg through to 2.4mg maintenance. Whether you're switching due to tolerability, efficacy, or prescriber preference, you'll never face the frustration of sourcing different doses from multiple pharmacies mid-treatment.
Complete Wegovy To Mounjaro Dose Pricing Structure
Wegovy pricing starts at £79.99 for 0.25mg starter pens, escalating through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for 2.4mg maintenance doses. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25. Our Getting Started bundles streamline the transition—the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is £189.99. These bundles provide convenient supply continuity during your escalation phase without multiple ordering cycles.
For patients requiring extended stays at lower doses before transitioning, our Take-It-Slow bundles offer flexibility. The Gentle Start Trio provides two 0.25mg pens plus one 0.5mg for £269.99, perfect for those who need longer adaptation periods. At maintenance level, our Ultimate Stability Trio delivers three months of 2.4mg supply for £649.99, ensuring consistent dosing without monthly reordering during the critical maintenance phase.
Clinical Evidence Supporting Wegovy To Mounjaro Decisions
In clinical trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme demonstrated sustained efficacy across diverse patient populations. Mounjaro's SURMOUNT trials showed different response patterns, though direct head-to-head comparisons aren't available due to varying trial designs and patient populations.
Both treatments require prescription-only medicine status and clinical assessment before switching. Your prescriber may recommend transitioning from Wegovy to Mounjaro based on individual response patterns, side effect profiles, or specific clinical considerations. The decision typically involves evaluating your progress at each dose level and determining which mechanism aligns best with your metabolic response and treatment goals.
How Wegovy Works Compared To Mounjaro's Dual Mechanism
Wegovy's semaglutide targets GLP-1 receptors in your brain's appetite centres, reducing hunger signals and promoting satiety after smaller meals. This single-pathway approach can effectively reduce food cravings and extend the feeling of fullness between meals. Mounjaro's tirzepatide activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors, creating a dual hormonal response that may provide different metabolic effects. Some patients respond better to this multi-target approach, particularly those with insulin resistance or specific metabolic profiles. The choice between single and dual receptor targeting depends on individual physiology and treatment response patterns.
Seamless Wegovy To Mounjaro Ordering Process
Switching from Wegovy to Mounjaro through EverydayMeds requires a 3-minute online clinical assessment covering your current dose, treatment duration, response patterns, and any side effects experienced. Our prescribers review your case within 3 working days (or 24 hours with express service), considering your Wegovy history before recommending appropriate Mounjaro starting doses. Most transitions don't restart at 0.25mg—your prescriber determines equivalent dosing based on your current Wegovy strength. Once approved, next-day delivery ensures no treatment gaps, with cold-chain transport maintaining medication integrity throughout the UK. Your complete treatment history remains with one clinical team, ensuring continuity of care.
Storage Advantages When Switching From Wegovy To Mounjaro
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable for 6 weeks at room temperature below 30°C once removed from refrigeration, versus Mounjaro's 21-day limit. This advantage becomes crucial during holidays, travel, or lifestyle changes when refrigerated storage isn't consistently available. Both treatments use pre-filled FlexTouch pens requiring weekly injections, but Wegovy's extended room temperature stability provides greater lifestyle flexibility. When switching from Wegovy to Mounjaro, patients often notice this storage difference during their first travel experiences. Proper storage planning becomes essential for maintaining treatment consistency, particularly during the transition period when you're adapting to new injection routines.
Complete Dose Escalation Support Throughout Wegovy To Mounjaro Transition
Managing your complete treatment journey from Wegovy to Mounjaro requires pharmacy expertise in both dose escalation protocols and cross-treatment transitions. Our clinical team maintains detailed protocols for switching at every dose level—whether you're transitioning from 0.5mg Wegovy to equivalent Mounjaro dosing, or moving from 2.4mg maintenance to Mounjaro's corresponding strength. This specialised transition management prevents common switching complications like dose gaps, over-escalation, or treatment interruptions that can reset your progress.
Unlike pharmacies stocking limited dose ranges, our complete inventory means your transition timing depends purely on clinical factors, never supply availability. Your prescriber can schedule the optimal switching point based on your response patterns, side effect profile, and treatment goals rather than working around pharmacy limitations. This comprehensive approach ensures your Wegovy to Mounjaro transition optimises continuation of progress rather than starting fresh.
Start Your Wegovy To Mounjaro Assessment Today
Ready to discuss switching from Wegovy to Mounjaro with complete dose availability? Our clinical assessment takes 3 minutes online, with express prescriber review available within 24 hours for urgent transitions. Use code FIRST40 for new customers or DOSE25 for returning patients—both applied automatically at checkout. Visit https://everydaymeds.co.uk/collections/wegovy to begin your assessment and explore our complete range of both treatments. With every dose in stock and expert transition management, your weight management journey continues without interruption. Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which treatment aligns best with your current progress and future goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
